Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
vemurafenib melatonin

increases exposure

Unknown Theoretical
vemurafenib midazolam

decreases exposure

Unknown Study
vemurafenib nadolol

increases exposure

Unknown Study
vemurafenib naldemedine

increases exposure

Unknown Study
vemurafenib nintedanib

increases exposure

Unknown Study
vemurafenib oral

increases exposure

Unknown Theoretical
vemurafenib phenindione

increases exposure

Unknown Study
vemurafenib phenothiazines

increases exposure

Unknown Theoretical
vemurafenib phosphodiesterasetype-

increases exposure

Unknown Theoretical
vemurafenib pibrentasvir

increases exposure

Unknown Theoretical
vemurafenib ranolazine

increases exposure

Unknown Theoretical
vemurafenib rasagiline

increases exposure

Unknown Study
vemurafenib relugolix

increases exposure

Unknown Study
vemurafenib riluzole

increases exposure

Unknown Theoretical
vemurafenib rimegepant

increases exposure

Unknown Theoretical
vemurafenib roflumilast

increases exposure

Unknown Theoretical
vemurafenib ropivacaine

increases exposure

Unknown Theoretical
vemurafenib talazoparib

increases exposure

Unknown Study
vemurafenib taxanes

increases exposure

Unknown Theoretical
vemurafenib tigecycline

increases exposure

Unknown Anecdotal
vemurafenib topotecan

increases exposure

Unknown Study
vemurafenib trametinib

increases concentration

Unknown Theoretical
vemurafenib triptans

increases exposure

Unknown Theoretical
vemurafenib venetoclax

increases exposure

Unknown Theoretical
vemurafenib vincaalkaloids

increases exposure

Unknown Theoretical
vemurafenib zolmitriptan

increases exposure

Unknown Theoretical
venetoclax antihistamines,non-sedating

increases exposure

Unknown Theoretical
venetoclax atorvastatin

increases exposure

Unknown Study
venetoclax bosentan

increases exposure

Unknown Theoretical
venetoclax coumarins

increases exposure

Unknown Study
venetoclax digoxin

increases exposure

Unknown Study
venetoclax endothelinreceptorantagonists

increases exposure

Unknown Theoretical
venetoclax fexofenadine

increases exposure

Unknown Theoretical
venetoclax fluvastatin

increases exposure

Unknown Theoretical
venetoclax glibenclamide

increases exposure

Unknown Theoretical
venetoclax livevaccines

decreases efficacy

Unknown Theoretical
venetoclax meglitinides

increases exposure

Unknown Theoretical
venetoclax pravastatin

increases exposure

Unknown Theoretical
venetoclax repaglinide

increases exposure

Unknown Theoretical
venetoclax rosuvastatin

increases exposure

Unknown Theoretical
venetoclax simvastatin

increases exposure

Unknown Theoretical
venetoclax statins

increases exposure

Unknown Theoretical
venetoclax sulfasalazine

increases exposure

Unknown Theoretical
venetoclax sulfonylureas

increases exposure

Unknown Theoretical
venetoclax topotecan

increases exposure

Unknown Theoretical
venetoclax warfarin

increases exposure

Unknown Study
venlafaxine haloperidol

increases exposure

Unknown Study
verapamil afatinib

increases exposure

Unknown Study
verapamil aliskiren

increases exposure

Unknown Study
verapamil anthracyclines

increases exposure

Unknown Study
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.